Combination Therapy for Cancerwith Judy A Mikovits
Having trouble viewing this video?Click here to load an audio-only version. Click here to load the full-resolution video.
What you'll learn from this expert talk:
- Disease impact of endocannabinoid system (ECS) activation
- Using whole-plant combinations
- Modulating the ECS with other botanicals
Judy A Mikovits
Judy Mikovits, PhD earned BA in Chemistry from University of Virginia in 1980 and a PhD in biochemistry and molecular biology from George Washington University in 1992. Her PhD thesis defense changed the paradigm for therapeutic treatment of HIV. For this work, she was awarded the graduate student of the year in 1991. In her thirty-five-year quest to understand and treat chronic diseases, she has co-authored seminal papers culminating at least a decade of research in each of four fields: immunology, natural products chemistry, epigenetics, and AIDS and cancer drug development. In 1999, she directed the Laboratory of Antiviral Drug Mechanisms developing therapeutics and diagnostics for HIV/AIDS and AIDS associated malignancies. These are therapies that are still standard of care twenty-five years later and credited with saving millions of deaths from HIV/AIDS.
In 2006, of families with neuro-immune diseases including ME/CFS and Autism, and she has been primarily responsible for demonstrating the relationship between environmental toxins, retroviruses and the development of acquired immune dysfunction and cancer. Throughout career she and her colleague, Dr. Frank Ruscetti, have translated their discoveries into curative immune therapeutic strategies for these diseases.
Dr. Mikovits has co-authored more than 50 peer reviewed publications and book chapters and the book Plague.